Skip to Main Content

Paper Details

Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function.
J Am Coll Cardiol
2
2023
Cardiovascular Death, Chronic Heart Failure, DAPA, Dapagliflozin, Deterioration in Renal Function, HF, Heart Failure, Patients, SGLT2, Sodium, Sodium-glucose cotransporter-2, chronic kidney disease, dapagliflozin, glucose, heart failure, participant, patients
Author NameAffiliation
Akshay S DesaiBrigham and Women's Hospital, Harvard Medical School
Rudolf A de BoerErasmus Medical Center
Adrian F HernandezDuke University Medical Center
Mikhail KosiborodSaint Luke's Mid America Heart Institute and University of Missouri
Carolyn S P LamDuke-National University of Singapore
Marc S SabatineBrigham and Women's Hospital, Harvard Medical School
Marc S SabatineBrigham and Women's Hospital, Harvard Medical School
  • 1 - 7

Datasets

Release 1.2